42. Shao JS, Towler DA. Molecular mechanism of vascular calcification: Lessons learned from the aorta. Arterioscl Thromb Vasc 2006;26:1423-1430.
43. Singleton JR, Smith AG, Bromberg MB. Painful sensory polyneuropathy associated with impaired glucose tolerance. Muscle nerve 2001;24(9):1109-1112.
44. Stevens A, Lowe J. Anatomía patológica. 2ed Madrid: Harconet; 2001:464.
45. Susuki E, Egawa K, Nishio Y, Maegawa H. Prevalence and major risk factors of reduced flow volumen in lower extremities with normal ankle-brachial index in japanese patients with type 2 diabetes. Diabetes Care 2003;26:1764-1769.
46. Susuki E, Kashiwagi A, Nishio Y, Egawa K. Increased arterial wall stiffness limits flow volumen in the lower extremities in type 2 diabetics patients. Diabetes care 2001;24:2107-2114.
47. Susuki E. Usefulness of wareform analysis of popliteal artery in type 2 diabetic patients using gated magnetic resonance 2D-line-PC-imaging ans P-31 spectroscopy. Diabetologia 2000;43(8):1031-1038.
48. Triana E. La hiperglicemia y sus efectos tóxicos. Un concepto patogénico para la micro y macroangiopatía diabética. Rev Cubana Angiol y Cir Vasc 2001;2)2):131-141.
49. Veves A, Matik RA. Clinical features of diabetic polyneuropathy. In: Diabetic neuropathy: Clinical management 2nd ed. Totowa, NJ, Humana Press, 2007, pp 243-258.
50. Vinik A, Simpson DM. The evolution of the diagnosis and management of painful diabetic peripheral neuropathy (Live Web Conference Sept. 22, 2008) Publicado en 10-16-2008 y Consultado en 9-9-2009. http://cmc. medscape. com/ neurology
51. Vinik AI. Small fibre neuropathy. Exp Clin Endocrinol Diabetes 2001;1099(Suppl 2):S451-S473.
52. Wein TH, Albers JW. Diabetic neuropathies. Phys Med Rehabil Clin Nam 2001;12(2):307-320.
53. Weisswasser JM, Arora S, Shuman C, Kellicut D, Sidawy AN. Diabetic neuropathy. Seminars in Vascular Surgery 2003;16(1):27-35.
54. Ziegler D. Risk factors for neuropathic pain. Eur J Pain 2008;7:7-17.